Suchergebnisse - Rukmini Kumar

Integrating Model‐Informed Drug Development With AI: A Synergistic Approach to Accelerating Pharmaceutical Innovation von Karthik Raman, Rukmini Kumar, Cynthia J. Musante, Subha Madhavan

Volltext

Quantitative systems pharmacology model of erythropoiesis to simulate therapies targeting anemia due to chronic kidney disease von Mrittika Roy, Shaifali Saroha, Uddipan Sarma, Harini Sarathy, Rukmini Kumar

Volltext

Incorporating lesion-to-lesion heterogeneity into early oncology decision making von Rukmini Kumar, Timothy Qi, Yanguang Cao, Yanguang Cao, Brian Topp

Volltext

Multiscale, mechanistic model of Rheumatoid Arthritis to enable decision making in late stage drug development von Dinesh Bedathuru, Maithreye Rengaswamy, Madhav Channavazzala, Tamara Ray, Prakash Packrisamy, Rukmini Kumar

Volltext

Beyond the single average tumor: Understanding IO combinations using a clinical QSP model that incorporates heterogeneity in patient response von Rukmini Kumar, Kannan Thiagarajan, Lakshmanan Jagannathan, Liming Liu, Kapil Mayawala, Dinesh deAlwis, Brian Topp

Volltext

Immunostimulatory and Immunodynamic Modeling Analysis to Determine a Plausible Starting Dose of mRNA‐4359 for Use in First‐In‐Human Trials von Stephen A. Greene, Madhav Channavazzala, Bhairav Paleja, Harshbir Singh Sandhu, Rukmini Kumar, Husain Attarwala, Linh Van, Min Liang

Volltext

Can a propensity score matching method be applied to assessing efficacy from single‐arm proof‐of‐concept trials in oncology? von Shu‐Wen Teng, Yu‐Cheng Su, Ravikumar Pallantla, Madhav Channavazzala, Rukmini Kumar, Yucheng Sheng, Hao Wang, Crystal Wang, Archie Tse

Volltext